Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.

Etherton MR, Wu O, Cougo P, Giese AK, Cloonan L, Fitzpatrick KM, Kanakis AS, Boulouis G, Karadeli HH, Lauer A, Rosand J, Furie KL, Rost NS.

Stroke. 2017 Dec;48(12):3387-3389. doi: 10.1161/STROKEAHA.117.019258. Epub 2017 Nov 10.

2.

Integrity of normal-appearing white matter and functional outcomes after acute ischemic stroke.

Etherton MR, Wu O, Cougo P, Giese AK, Cloonan L, Fitzpatrick KM, Kanakis AS, Boulouis G, Karadeli HH, Lauer A, Rosand J, Furie KL, Rost NS.

Neurology. 2017 May 2;88(18):1701-1708. doi: 10.1212/WNL.0000000000003890. Epub 2017 Apr 5.

3.

Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke.

Nelson S, Cloonan L, Kanakis AS, Fitzpatrick KM, Shideler KI, Perilla AS, Furie KL, Rost NS.

J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2519-25. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.032. Epub 2016 Jul 18.

PMID:
27444522
4.

Determinants of white matter hyperintensity burden in patients with Fabry disease.

Rost NS, Cloonan L, Kanakis AS, Fitzpatrick KM, Azzariti DR, Clarke V, Lourenco CM, Germain DP, Politei JM, Homola GA, Sommer C, Üçeyler N, Sims KB.

Neurology. 2016 May 17;86(20):1880-6. doi: 10.1212/WNL.0000000000002673. Epub 2016 Apr 20.

5.

Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke.

Traylor M, Zhang CR, Adib-Samii P, Devan WJ, Parsons OE, Lanfranconi S, Gregory S, Cloonan L, Falcone GJ, Radmanesh F, Fitzpatrick K, Kanakis A, Barrick TR, Moynihan B, Lewis CM, Boncoraglio GB, Lemmens R, Thijs V, Sudlow C, Wardlaw J, Rothwell PM, Meschia JF, Worrall BB, Levi C, Bevan S, Furie KL, Dichgans M, Rosand J, Markus HS, Rost N; International Stroke Genetics Consortium.

Neurology. 2016 Jan 12;86(2):146-53. doi: 10.1212/WNL.0000000000002263. Epub 2015 Dec 16.

6.

FLAIR Vascular Hyperintensity is a Surrogate of Collateral Flow and Leukoaraiosis in Patients With Acute Stroke Due to Proximal Artery Occlusion.

Karadeli HH, Giurgiutiu DV, Cloonan L, Fitzpatrick K, Kanakis A, Ozcan ME, Schwamm LH, Rost NS.

J Neuroimaging. 2016 Mar-Apr;26(2):219-23. doi: 10.1111/jon.12274. Epub 2015 Aug 6.

7.

Role of Acute Lesion Topography in Initial Ischemic Stroke Severity and Long-Term Functional Outcomes.

Wu O, Cloonan L, Mocking SJ, Bouts MJ, Copen WA, Cougo-Pinto PT, Fitzpatrick K, Kanakis A, Schaefer PW, Rosand J, Furie KL, Rost NS.

Stroke. 2015 Sep;46(9):2438-44. doi: 10.1161/STROKEAHA.115.009643. Epub 2015 Jul 21.

8.

Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.

Cloonan L, Fitzpatrick KM, Kanakis AS, Furie KL, Rosand J, Rost NS.

Atherosclerosis. 2015 May;240(1):149-53. doi: 10.1016/j.atherosclerosis.2015.02.052. Epub 2015 Mar 2.

9.

Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.

Zhang CR, Cloonan L, Fitzpatrick KM, Kanakis AS, Ayres AM, Furie KL, Rosand J, Rost NS.

J Stroke Cerebrovasc Dis. 2015 Mar;24(3):649-54. doi: 10.1016/j.jstrokecerebrovasdis.2014.10.016. Epub 2014 Nov 6.

10.

Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke.

Adib-Samii P, Devan W, Traylor M, Lanfranconi S, Zhang CR, Cloonan L, Falcone GJ, Radmanesh F, Fitzpatrick K, Kanakis A, Rothwell PM, Sudlow C, Boncoraglio GB, Meschia JF, Levi C, Dichgans M, Bevan S, Rosand J, Rost NS, Markus HS.

Stroke. 2015 Feb;46(2):348-53. doi: 10.1161/STROKEAHA.114.006849. Epub 2014 Dec 30.

11.

Segmentation of cerebrovascular pathologies in stroke patients with spatial and shape priors.

Dalca AV, Sridharan R, Cloonan L, Fitzpatrick KM, Kanakis A, Furie KL, Rosand J, Wu O, Sabuncu M, Rost NS, Golland P.

Med Image Comput Comput Assist Interv. 2014;17(Pt 2):773-80.

12.

Determinants of early outcomes in patients with acute ischemic stroke and proximal artery occlusion.

LaBuzetta JN, Yoo AJ, Ali S, Fitzpatrick K, Leslie-Mazwi T, Hirsch JA, Schwamm L, Rost N.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2527-32. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.020. Epub 2014 Sep 18.

13.

Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke.

Giurgiutiu DV, Yoo AJ, Fitzpatrick K, Chaudhry Z, Leslie-Mazwi T, Schwamm LH, Rost NS.

J Neurointerv Surg. 2015 May;7(5):326-30. doi: 10.1136/neurintsurg-2013-011083. Epub 2014 Apr 10.

PMID:
24721756
14.

Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study.

Rost NS, Sadaghiani S, Biffi A, Fitzpatrick KM, Cloonan L, Rosand J, Shibata DK, Mosley TH Jr.

J Neurosci Methods. 2014 Jan 15;221:196-201.

15.

17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status.

Adib-Samii P, Rost N, Traylor M, Devan W, Biffi A, Lanfranconi S, Fitzpatrick K, Bevan S, Kanakis A, Valant V, Gschwendtner A, Malik R, Richie A, Gamble D, Segal H, Parati EA, Ciusani E, Holliday EG, Maguire J, Wardlaw J, Worrall B, Bis J, Wiggins KL, Longstreth W, Kittner SJ, Cheng YC, Mosley T, Falcone GJ, Furie KL, Leiva-Salinas C, Lau BC, Saleem Khan M; Australian Stroke Genetics Collaborative; Wellcome Trust Case-Control Consortium-2 (WTCCC2); METASTROKE, Sharma P, Fornage M, Mitchell BD, Psaty BM, Sudlow C, Levi C, Boncoraglio GB, Rothwell PM, Meschia J, Dichgans M, Rosand J, Markus HS; International Stroke Genetics Consortium.

Stroke. 2013 Jun;44(6):1609-15. doi: 10.1161/STROKEAHA.113.679936. Epub 2013 May 14.

16.

Quantification and Analysis of Large Multimodal Clinical Image Studies: Application to Stroke.

Sridharan R, Dalca AV, Fitzpatrick KM, Cloonan L, Kanakis A, Wu O, Furie KL, Rosand J, Rost NS, Golland P.

Multimodal Brain Image Anal (2013). 2013;8159:18-30. doi: 10.1007/978-3-319-02126-3_3.

17.

Implementation of a patient selection protocol for intra-arterial therapy increases treatment rates in patients with acute ischemic stroke.

Rost NS, Smith EE, Nogueira RG, Fitzpatrick KM, Yoo AJ, Hirsch JA, Schwamm LH.

J Neurointerv Surg. 2013 May;5 Suppl 1:i44-7. doi: 10.1136/neurintsurg-2011-010240. Epub 2012 May 18.

18.

White matter hyperintensity burden and susceptibility to cerebral ischemia.

Rost NS, Fitzpatrick K, Biffi A, Kanakis A, Devan W, Anderson CD, Cortellini L, Furie KL, Rosand J.

Stroke. 2010 Dec;41(12):2807-11. doi: 10.1161/STROKEAHA.110.595355. Epub 2010 Oct 14.

Supplemental Content

Loading ...
Support Center